Abzena to issue ordinary shares
January 24, 2017Abzena has made application to the London Stock Exchange for the admission of 715,772 new ordinary shares of £0.002 each (‘New Ordinary Shares’) to trading on AIM.
The company has made application in accordance with the completion of the initial vesting period of the restricted stock units issued to employees on the acquisition of The Chemical Research Solution LLC (known as ‘TCRS’) in December 2015.
Admission of the New Ordinary Shares is expected to take place at 8:00am on 27 January 2017.
Following admission of the New Ordinary Shares to AIM, the Company’s enlarged issued share capital will comprise 137,846,327 ordinary shares of £0.002 each with voting rights. No shares of the Company are held in treasury.
